Ebola Vaccine proves effective against Zaire strain

Usually most of the daily news is bad but today we woke up to very good news.  rVSV-ZEBOV, a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus has completed phase 1 human trials in Guinea, West Africa.  Vaccine efficacy was 100%  Fast track this one please (Merck has 300,000 doses ready in case of an outbreak).  We are highly impressed by this work and hope it will serve as a model for the future of rapid drug development and deployment in response to emerging epidemics.   

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32621-6/fulltext

blog of interest

With final exams looming large I am not updating this blog too much right now -  I recommend checking out Jean Peccoud's blog here. I'll be back😸.